
Johnson & Johnson has sold its Ortho-Clinical Diagnostics (OCD) business to private equity investor The Carlyle Group for ‘approximately $4 …

Johnson & Johnson has been offered $4.15 billion by private equity firm The Carlyle Group to buy its Ortho-Clinical Diagnostics …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

